Tag Archives: COVID19

How COVID-19 drug/vaccine decisions might be based on little evidence

At this point, the Food and Drug Administration could grant emergency-use authorization. In other words, the two vaccines could hinge on the combined results of 64 people. Haseltine concludes: If — or perhaps when — positive early results from these trials are announced, keep my warnings in mind. These protocols seem designed to get a… Read More »

FDA Approves Veklury (remdesivir) for the Treatment of COVID-19

FDA Approves Veklury (remdesivir) for the Treatment of COVID-19 FOSTER CITY, Calif.–(BUSINESS WIRE)–Oct. 22, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. As an antiviral drug, Veklury works to stop replication… Read More »

COVID-19 virus can survive on phone screens 'for 28 days'

The virus responsible for COVID-19, SARS-CoV-2, can survive on surfaces such as phone screens and bank notes for up to 28 days, research from Australia’s national science agency CSIRO has found. The Australian agency published its results in Virology Journal last week of a study it conducted into how long the virus can survive outside… Read More »

NYU combines AI and EHR data to assess COVID-19 outcomes

New York University researchers have developed a model to predict favorable four-day outcomes among COVID-19 patients. Based on real-time lab values, vital signs and oxygen support variables, the model – which researchers say has 90% precision – may help clinicians to determine which patients can be safely discharged. “Discharging patients safely to free up beds… Read More »